Verve Therapeutics presented interim data from its heart-1 Phase 1b clinical trial of VERVE-101, an investigational medicine for lowering cholesterol, at a scientific conference.
AI Assistant
VERVE THERAPEUTICS INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.